Phase II study: systemic treatment with iv [intravenous] ZK219477-Epothilone [sagopilone] in recurrent glioblastoma patients
Latest Information Update: 18 Aug 2015
At a glance
- Drugs Sagopilone (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 25 Nov 2006 New trial record.